about us | newsletter | contact | archive | members area
FLORIN POPA, BUSINESS TO BUSINESS DIRECTOR, ORANGE
Our vision is that we must allow embedding standards that combine infrastructures»
  News:      POLITICS   |   ECONOMICS   |   ENERGY   |   INVESTMENTS   |   APPOINTMENTS   |   GREEN   |   INFRASTRUCTURE   |   REAL ESTATE   |   AGRIBUSINESS   |   DRIVING   |   CITY LIFE   |   EVENTS   |

Cegedim: Pharmaceutical segment in Romania loses 4 per cent in Q1 and reaches 669 million Euro

The pharmaceutical products sales in Romania, reflected in the distribution price decreased by four per cent in Q1 this year compared to the same interval of 2013 and reached a total value of 668.8 million Euro, under expectations, according to Cegedim data.

2014-05-20 10:54:21

Petru Craciun, general manager of Cegedim states that the slightly warmer winter is accountable for the results. For 2014, in the context of a yet not updated subsidized medicine product list, the estimates take into account a decrease from 2.7 per cent to -0.3 per cent in local currency for the market. The decrease in lei for the Q1 was estimated at 1.5 per cent, to 3 billion lei.

In Q1, the pharmaceutical retail segment for Rx products reached 471.7 million Euro (2.12 billion lei), 2.2 per cent less while OTCs accounted for 109 million Euro (490 million lei), increased value of 2.4 per cent. The overall retail decreased in Q1 with 3.9 per cent and reached 580.6 million Euro, while other distribution channels such as hospitals increased with 4.9 per cent to 88.2 million Euro.

The company ranking for this market is led by Servier with 673.3 million lei and increase of 5.8 per cent, Pfizer with 600.1 million lei and 5.1 per cent increase, GlaxoSmithKline (510,3 million lei and 4,4 per cent), Ranbaxy (464,6 million lei and 4 per cent), Merck&Co (450,5 million lei and 3,8 per cent), AstraZeneca (440,3 million lei and 3,8 per cent) and Krka (316 million lei and 2,7 per cent).

They are followed by Johnson&Johnson, Antibiotice, Abbvie, Teva, Menarini, Bayer, Bristol Myers Squibb, Alvogen, Actavis and Eli Lilly, with market shares between 2.5 per cent and 1.6 per cent.



COMMENTS
There are 0 comments:

 
ADD A COMMENT
 
Name
Email
Comment
Validation Code
   
 
 

0 Comments  |  1980 Views
Daily Info
Intelligence Service's heads to be heard on 25 January by Parliamentary Oversight Committee in Coldea case

The Parliamentary Oversight Committee regarding the Romanian Intelligence Service (SRI) activity will hear the SRI heads in the January 25 session in relation to Florian Colde...

JusMin: I will have a talk with PM on the amnesty and pardon law

Justice Minister Florin Iordache says he will have a talk with Prime Minister Sorin Grindeanu on the amnesty and pardon law, according to Agerpres.

Presidency: Romania to be represented by its ambassador in Washington at Donald Trump's investiture ceremony

Romania will be represented at the inauguration ceremony of the United States of America's President-elect Donald Trump by the country's ambassador in Washington, since no for...

InterContinental Bucharest appoints new general manager

InterContinental Bucharest appoints a new general manager, in the person of Lior Bebera. He is replacing Stefan Frank, after being more than four years in this position, a pre...

ForMin Melescanu to participate in Foreign Affairs Council meeting

Foreign Affairs Minister Teodor Melescanu will participate on Monday, January 16, together with the counterparts of the European Union member states, in the monthly meeting of...

 
 
   
advertising

advertising

advertising

advertising

advertising

advertising

More on News
Energy Performance Contracting for public buildings

The Romanian Association for Promoting Energy Efficiency (ARPEE), established in 2012, has as overall scope the mobilization of its members’ resources and competences to ...

Romania takes over rotating presidency of Open Skies Consultative Commission

Romania has taken over the rotating presidency of the Open Skies Consultative Commission (OSCC), and in late September, it chaired the first meeting in a series of four for...

Six companies shortlisted to benefit from state aid for new investment projects

The Finance Ministry has selected six companies out of 36 applicants to grant them state aid for new investment projects that would positively impact the local economy

Providers forced to purchase gas only through the stock exchange

The Romanian Government adopted, in late September, an emergency ordinance governing the obligation of suppliers to purchase gas delivered to domestic customers “on the b...

CTP to invest 250 million Euro in Romania so far

CTP, one of the largest investors and developers of logistics projects in Romania, has invested 250 million Euro on the local market so far, according to a press release is...

The government approved the General Masterplan for transport

The government approved in the meeting on Wednesday the General masterplan for transport of Romania, announced Minister of Transport Sorin Buse

Romania’s first residential complex with green energy sold 200 apartments in first phase

Cartierul Solar, the first residential complex with green energy in Romania, located in southern Bucharest and developed by Ad Astra Partners, has completed its first phase...